Reata Pharmaceuticals Inc (RETA) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering Reata Pharmaceuticals Inc.
| Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|
| 9 | $322 | $155 | $232.11 | $81.62 | 184.38% |
The Trend in the Analyst Price Target
Over the past 121 days, RETA's average price target has gone down $13.39.
Over the past 332 days, RETA's average upside potential has been 107.01%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-05-08 | 9 | 322 | 155 | 232.11 | 85.06 | 172.88% |
| 2021-04-25 | 8 | 322 | 200 | 243.38 | 88.41 | 175.29% |
| 2021-04-17 | 8 | 322 | 200 | 243.38 | 90.87 | 167.83% |
| 2021-04-10 | 8 | 322 | 200 | 243.38 | 88.42 | 175.25% |
| 2021-04-03 | 8 | 322 | 200 | 243.38 | 100.62 | 141.88% |
| 2021-03-20 | 8 | 322 | 200 | 243.38 | 115.66 | 110.43% |
| 2021-03-13 | 8 | 322 | 200 | 243.38 | 132.81 | 83.25% |
| 2021-03-03 | 8 | 322 | 200 | 243.38 | 129.86 | 87.42% |
| 2021-02-27 | 8 | 320 | 212 | 246.75 | 122.26 | 101.82% |
| 2021-02-20 | 8 | 320 | 212 | 246.75 | 125.28 | 96.96% |
| 2021-02-13 | 8 | 320 | 212 | 246.75 | 123.75 | 99.39% |
| 2021-02-06 | 8 | 320 | 212 | 246.75 | 114.95 | 114.66% |
| 2021-01-30 | 8 | 320 | 212 | 246.75 | 103.59 | 138.2% |
| 2021-01-23 | 8 | 320 | 212 | 246.75 | 113.37 | 117.65% |
| 2021-01-16 | 8 | 320 | 212 | 246.75 | 111.93 | 120.45% |
| 2021-01-07 | 8 | 320 | 212 | 245.50 | 125.00 | 96.4% |
| 2020-12-30 | 8 | 320 | 212 | 245.50 | 125.01 | 96.38% |
| 2020-12-26 | 8 | 320 | 212 | 245.50 | 132.55 | 85.21% |
| 2020-12-19 | 8 | 320 | 212 | 245.50 | 121.63 | 101.84% |
| 2020-12-10 | 8 | 320 | 212 | 245.50 | 123.89 | 98.16% |
| 2020-12-07 | 8 | 320 | 212 | 245.50 | 133.95 | 83.28% |
| 2020-11-28 | 8 | 320 | 212 | 245.50 | 157.26 | 56.11% |
| 2020-11-09 | 7 | 345 | 212 | 255.43 | 174.66 | 46.24% |
| 2020-10-24 | 8 | 345 | 169 | 236.25 | 117.28 | 101.44% |
| 2020-08-10 | 8 | 345 | 169 | 236.25 | 104.41 | 126.27% |
| 2020-07-29 | 8 | 345 | 237 | 281.12 | 154.20 | 82.31% |
| 2020-07-09 | 8 | 345 | 237 | 281.12 | 156.12 | 80.07% |
| 2020-06-30 | 8 | 345 | 237 | 285.50 | 156.02 | 82.99% |
| 2020-06-13 | 8 | 345 | 237 | 285.50 | 163.25 | 74.89% |
| 2020-06-13 | 7 | 345 | 254 | 292.43 | 163.25 | 79.13% |
| 2020-06-10 | 7 | 345 | 254 | 292.43 | 130.92 | 123.37% |
RETA Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.12 | 6 | 2 | 0 | 0 | 0 | 8 |
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for RETA as an investment opportunity.
- Reata Pharmaceuticals Inc's average analyst price target is higher than 95.03% of all US stocks.
- The upside potential (average analyst target price relative to current price) of RETA is higher than 97.88% of stocks in the mid market cap category.
- Reata Pharmaceuticals Inc's variance in analysts' estimates is less than 12% of all US stocks.
- RETA has a greater number of analysts covering the stock than 81.02% of Pharmaceutical Products stocks.
Stocks similar to Reata Pharmaceuticals Inc in the Pharmaceutical Products industry regarding analyst recommendations and price targets are ETNB, ALBO and MIRM.
Is RETA a Buy, Hold or Sell? See the POWR Ratings now!